CD276 and head and neck cancer: In head and neck cancers, B7-H3 has been shown to exhibit pleiotropic activity by reshaping the immune microenvironment and influencing non-immunological processes, such as the maintenance of cancer stem cell populations and the inducing epithelial-to-mesenchymal transition.